Clinical Trial Update: Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C [NA]

View source ↗

Summary

A completed clinical trial evaluating the OPTIMIZER System for safety and efficacy in moderate-to-severe heart failure (NYHA Class III/IV). Results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• OPTIMIZER system

Snippet

Sponsor: Impulse Dynamics | Conditions: NYHA Class III Heart Failure, NYHA Class IV Heart Failure | NA | Status: COMPLETED | Results posted: 2021-09-17